AGILENT TECHNOLOGIES INC (A) Stock News
NYSE:A - New York Stock Exchange, Inc. - US00846U1016 - Common Stock - Currency: USD
A Latest News, Press Relases and Analysis
Wondering what's happening in today's S&P500 pre-market session?
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
1 Profitable Stock That Stand Out and 2 to Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research
Strong Segmental Performance to Drive Stryker's Q1 Earnings?
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Will BAX's Q1 Earnings Improve Following Transformation Completion?
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Are Options Traders Betting on a Big Move in Agilent Technologies Stock?
Investors need to pay close attention to A stock based on the movements in the options market lately.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Mentions: AZN
Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Agilent to Announce Second-Quarter Fiscal Year 2025 Financial Results on May 28
Analyst Says Apple (AAPL) Needs ‘More Than’ Executive Shakeup Amid Its ‘Vulnerability’
We recently published a list of 10 Stocks Everyone is Talking About After Trump’s New Tariffs. In this article, we are going to take a look at where Apple Inc (NASDAQ:AAPL) stands against other stocks everyone is talking about after Trump’s new tariffs. Countries are beginning to react to President Donald Trump’s new reciprocal tariffs […]
The CEO of CoreWeave explains why they went public—And why they scaled back their initial offer
The much-anticipated debut is being seen as a litmus test for other AI companies.
Cardinal Health (CAH): A Top Pick For The Best Retirement Portfolio
We recently published the Best Retirement Portfolio for a 65-Year-Old. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks in the best retirement portfolio. The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing […]
Visa Inc. (V): A Top Pick For The Best Retirement Portfolio
We recently published the Best Retirement Portfolio for a 65-Year-Old. In this article, we are going to take a look at where Visa Inc. (NYSE:V) stands against other stocks in the best retirement portfolio. The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing down […]
Agilent Technologies (A): A Top Pick For The Best Retirement Portfolio
We recently published the Best Retirement Portfolio for a 65-Year-Old. In this article, we are going to take a look at where Agilent Technologies, Inc. (NYSE:A) stands against other stocks in the best retirement portfolio. The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing […]
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
Agilent to Participate in TD Cowen Health Care Conference
Agilent’s (NYSE:A) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations
Life sciences tools company Agilent Technologies (NYSE:A) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 1.4% year on year to $1.68 billion. On the other hand, next quarter’s revenue guidance of $1.63 billion was less impressive, coming in 1.4% below analysts’ estimates. Its GAAP profit of $1.11 per share was in line with analysts’ consensus estimates.
